首页 | 本学科首页   官方微博 | 高级检索  
检索        

氧化还原信号调控与肿瘤代谢
引用本文:王魁,明慧,左静,田海隆,黄灿华.氧化还原信号调控与肿瘤代谢[J].四川大学学报(医学版),2021,52(1):57-63.
作者姓名:王魁  明慧  左静  田海隆  黄灿华
作者单位:四川大学华西医院生物治疗国家重点实验室生物治疗协同创新中心,成都 610041;四川大学华西基础医学与法医学院,成都 610041;四川大学华西基础医学与法医学院,成都 610041;四川大学华西医院生物治疗国家重点实验室生物治疗协同创新中心,成都 610041
基金项目:国家自然科学基金(No. 81821002、No. 81790251、No. 81872277、No. 82073081),国家重点研发计划(No. 2020YFA0509400、No. 2020YFC2002705),广东省基础与应用基础研究重大项目(No. 2019B030302012)和四川省科技计划项目(No. 2020YJ0107)资助
摘    要:代谢异常是肿瘤细胞的十大特征之一,肿瘤细胞能够通过代谢重编程满足其快速增殖的物质和能量需求。肿瘤代谢重编程伴随活性氧(reactive oxygen species,ROS)的产生以及抗氧化体系的激活。ROS含量过高会导致氧化损伤甚至细胞死亡,而适量水平的ROS可作为第二信使参与调控多种信号通路。近年来,随着对氧化应激研究的不断深入,发现ROS可直接介导蛋白质发生氧化还原修饰(redox modifications),从而造成蛋白质构象或功能的改变。然而,目前仅报道了3-磷酸甘油醛脱氢酶(glyceraldehyde-3-phosphate dehydrogenase,GAPDH)、M2型丙酮酸激酶(PKM2)等个别代谢酶的氧化还原修饰,其他代谢酶是否受到氧化还原修饰调控并发挥重要功能尚不清楚,靶向代谢酶氧化还原修饰的时空特异性和代偿适应性也是目前的重点和难点。本文将从肿瘤代谢的角度出发,综述近年来报道的有关代谢酶的氧化还原修饰模式、调控机制及其在肿瘤发生发展中的作用,探讨和展望靶向代谢酶氧化还原修饰的肿瘤治疗策略。

关 键 词:肿瘤代谢  活性氧  氧化应激  氧化还原修饰  肿瘤治疗
收稿时间:2020-11-09

A Review of the Redox Regulation of Tumor Metabolism
WANG Kui,MING Hui,ZUO Jing,TIAN Hai-long,HUANG Can-hua.A Review of the Redox Regulation of Tumor Metabolism[J].Journal of West China University of Medical Sciences,2021,52(1):57-63.
Authors:WANG Kui  MING Hui  ZUO Jing  TIAN Hai-long  HUANG Can-hua
Institution:1.Collaborative Innovation Center for Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China
Abstract:Metabolic aberrance is one of the hallmarks of cancer. The metabolic patterns in cancer cells are well reprogrammed to provide building blocks and energy for their sustained growth. During tumor metabolic reprogramming, reactive oxygen species (ROS) are generated and the antioxidant systems are activated. High levels of ROS lead to oxidative damage and even cell death, whereas ROS at low levels act as second messenger to regulate many signaling pathways. Recently, with the revisiting of oxidative stress, it has been found that ROS can directly mediate the redox modifications of proteins, resulting in protein conformational and functional alterations. However, only a very small portion of metabolic enzymes, including glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and PKM2, etc., has been reported to undergo redox modifications. Whether other metabolic enzymes are regulated by redox modifications and thus exhibit critical functions remain largely unknown. Moreover, the specific spatio-temporal targeting of redox modifications of metabolic enzymes, as well as overcoming the existed redox and metabolic adaptation, are key points to be solved. Here, we will review the reported redox modification patterns of metabolic enzymes, the involved regulatory mechanisms and their roles in tumorigenesis and tumor progress. In addition, we will discuss the future therapeutic strategies targeting redox modifications of metabolic enzymes for tumor treatment.
Keywords:
本文献已被 万方数据 等数据库收录!
点击此处可从《四川大学学报(医学版)》浏览原始摘要信息
点击此处可从《四川大学学报(医学版)》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号